Table 3.
15–24 years | 25–49 years | |||
---|---|---|---|---|
Year | Seroconversion (PY) | HIV incidence (95% CI) | Seroconversion (PY) | HIV incidence (95% CI) |
2010 | 2 (45.96) | 4.35 (1.09–17.40) | 2 (27.61) | 7.24 (1.81–28.96) |
2011 | 1 (36.72) | 2.72 (0.38–19.33) | 0 (23.92) | 0 |
2012 | 2 (28.29) | 7.07 (1.77–28.27) | 0 (22.14) | 0 |
2013 | 1 (19.78) | 5.06 (0.71–35.89) | 0 (19.45) | 0 |
2014 | 0 (11.46) | 0 | 1 (15.58) | 6.42 (0.90–45.58) |
2015a | 1 (4.08) | 24.51 (3.45–174.02) | 1 (6.7) | 14.92 (2.10–105.92) |
aSome pregnancies in the later part of 2015 would be reported in the first surveillance round in 2016 when women disclose their pregnancy to the household or attend antenatal care; hence 2015 does not include all women who may have been pregnant in 2015